The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke

PHASE3RecruitingINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

September 6, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

April 30, 2026

Conditions
StrokeAcute StrokeIschemic StrokeCerebrovascular DisordersPhysiological Effects of Drugs
Interventions
DRUG

Dimephosphon®

1 g/ml, concentrate for solution for intravenous infusion

DRUG

Placebo

Placebo IV solution

Trial Locations (6)

117198

RECRUITING

"Federal State Autonomous Educational Institution of Higher Education Peoples' Friendship University of Russia named after Patrice Lumumba", Moscow

117513

RECRUITING

"The FSBI Federal Center of Brain Research and Neurotechnologies of the Federal Medical and Biological Agency", Moscow

188643

RECRUITING

"State Budgetary Healthcare Institution of the Leningrad Region Vsevolozhsk Interdistrict Clinical Hospital", Vsevolozhsk

197706

RECRUITING

"Saint Petersburg State Budgetary Healthcare Institution City Hospital No. 40 of the Kurortny District", Saint Petersburg

350086

NOT_YET_RECRUITING

"State Budgetary Healthcare Institution Research Institute - Regional Clinical Hospital No. 1 named after Professor S.V. Ochapovsky of the Ministry of Health of the Krasnodar region", Krasnodar

354057

RECRUITING

"State Budgetary Healthcare Institution City Hospital No. 4 of Sochi of the Ministry of Healthcare of the Krasnodar Region", Sochi

All Listed Sponsors
lead

Tatchempharmpreparaty, JSC

INDUSTRY